Skip to main content
Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd. — Investor Relations & Filings

Ticker · DRTS ISIN · IL0011839466 US Professional, scientific and technical activities
Filings indexed 191 across all filing types
Latest filing 2026-05-04 Foreign Filer Report
Country US United States of America
Listing US DRTS

About Alpha Tau Medical Ltd.

https://www.alphatau.com/

Alpha Tau Medical Ltd. is a clinical-stage oncology company focused on the research, development, and commercialization of its proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) technology. This platform is designed for the treatment of solid tumors by delivering a high dose of alpha radiation directly into the tumor mass. The Alpha DaRT technology aims to destroy cancerous cells while sparing surrounding healthy tissues. The company is advancing its technology through clinical trials for various indications, including recurrent glioblastoma and prostate cancer, to evaluate its safety and efficacy as a potential cancer treatment.

Recent filings

Filing Released Lang Actions
6-K - Alpha Tau Medical Ltd. (0001871321) (Filer)
Foreign Filer Report
2026-05-04 English
6-K - Alpha Tau Medical Ltd. (0001871321) (Filer)
Foreign Filer Report
2026-04-27 English
6-K - Alpha Tau Medical Ltd. (0001871321) (Filer)
Foreign Filer Report
2026-04-23 English
6-K - Alpha Tau Medical Ltd. (0001871321) (Filer)
Foreign Filer Report
2026-03-31 English
3 - Alpha Tau Medical Ltd. (0001871321) (Issuer)
Director's Dealing
2026-03-19 English
3 - Alpha Tau Medical Ltd. (0001871321) (Issuer)
Director's Dealing
2026-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.